Our CEO Immanuel Lerner will be attending & presenting at the NextGen Biomed 2025 in London, March 12-13
Join our CEO, Immanuel Lerner for insights on AI-driven peptide drug discovery:📅 March 12:🗝 Keynote – Orally Available Peptides | 9:55 AM💡 Panel – Novel Peptide Therapeutics | 12:30 PM 📅 March 13:🎙 Moderator – Optimizing Drug Candidates | 2:15 PM
Our CEO Immanuel Lerner will be presenting at the DDIF 15th Annual Drug Discovery Innovation Forum in Berlin on September 5th
Our CEO Immanuel Lerner has been selected to speak at the #DDIF 15th Annual Drug Discovery Innovation Forum in Berlin, on September 4-5, 2024!
Our COO Maayan Elias Robicsek will attend Biomed Israel 2025, May 21-23/2024
Our COO Maayan Elias Robicsek is attending Biomed Israel 2025! Come and say hello to learn about our AI drug discovery platform
“Exploration Science” episode hosting our CEO Immanuel Lerner, and Head of Research, Amit Michaeli
Dr. Wendy Hartsock hosted our CEO, Immanuel Lerner, and Head of Research, Amit Michaeli on an episode of CEM Corporation‘s “Exploration Science”. They discussed the advantages of employing biocomputational AI to accelerate peptide discovery.You can tune in to the whole interview here:Youtube: http://ow.ly/SkgW50NPnmvSpotify: http://ow.ly/YTON50NPo0S
Our CEO and co-founder, Dr. Immanuel Lerner will be speaking at TIDES Asia 2023
Dr. Immanuel Lerner, CEO and co-founder of Pepticom, will speak at the TIDES Asia conference between March 7-9. His lecture will be about The Potential and Current Application of Artificial Intelligence in Peptide Drug Discovery. The conference will take place in Kyoto, from March 7-9, and he will be available for meetings there as well […]
Pepticom is launching a Webinar series
The webinar series is about the world of Peptide Therapeutics, in the first couple of episodes we are hosting Dr. Tomi Sawyer, our head of the scientific advisory board. We’ll share breakthroughs in the field, what the future is and where Pepticom fits in.To watch all episodes, follow us here: https://pepticom.com/to-our-webinar/